SCHEMBL19768478

SCHEMBL19768478

c1ccc2ncc(-c3ccc(-c4ccc5ccc6c(-c7ccc8ccc9ccc(-c%10cncc%11ccccc%10%11)nc9c8n7)ccc7ccc4c5c76)cn3)cc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ERN1 O75460 1/20 0.39
▸ PIK3CD O00329 1/20 0.38
▸ PIK3CA P42336 1/20 0.38
▸ CYP11B1 P15538 6/20 0.38
▸ CYP11B2 P19099 6/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2B6 P20813 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ PRKCZ Q05513 2/20 0.37
▸ CYP2A6 P11509 1/20 0.37
▸ PDGFRB P09619 2/20 0.36
▸ PDGFRA P16234 2/20 0.36
▸ CYP17A1 P05093 1/20 0.35
▸ GRM4 Q14833 1/20 0.35
▸ SLC22A12 Q96S37 1/20 0.34
▸ TOP2A P11388 1/20 0.33
▸ TOP2B Q02880 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19768529 0.87 PDGFRB (0.40) ERN1PIK3CDPIK3CACYP11B1CYP11B2
SCHEMBL19768456 0.85 CYP2A6 (0.38) PIK3CDPIK3CACYP2A6PDGFRBPDGFRA
SCHEMBL19768513 0.85 PRKCZ (0.42) ERN1CYP11B1CYP11B2CYP3A4CYP1A2
SCHEMBL19768480 0.83 CYP2A6 (0.54) PIK3CACYP11B1CYP11B2CYP3A4CYP2C9
SCHEMBL19768459 0.83 CYP2A6 (0.43) PIK3CDPIK3CACYP2A6PDGFRBPDGFRA
SCHEMBL16483096 0.83 PRKCZ (0.49) ERN1PIK3CDPIK3CACYP11B1CYP11B2
SCHEMBL19767985 0.83 CYP2A6 (0.42) PIK3CDPIK3CACYP2A6PDGFRBPDGFRA
SCHEMBL19768511 0.81 CYP2A6 (0.54) PIK3CDPIK3CACYP11B1CYP11B2CYP2A6
SCHEMBL19768275 0.81 CYP2A6 (0.40) PIK3CDPIK3CACYP2A6PDGFRBPDGFRA
SCHEMBL19768523 0.81 CYP2A6 (0.43) PIK3CDPIK3CACYP2A6PDGFRBPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180019407-A1 PHENANTHROLINE DERIVATIVE, ELECTRONIC DEVICE CONTAINING SAME, LIGHT EMITTING ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT TORAY INDUSTRIES, INC (JP) 2018-01-18 — — US disclosed
US-20180019407-A1 PHENANTHROLINE DERIVATIVE, ELECTRONIC DEVICE CONTAINING SAME, LIGHT EMITTING ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT TORAY INDUSTRIES, INC (JP) 2018-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180019407-A1 PHENANTHROLINE DERIVATIVE, ELECTRONIC DEVICE CONTAINING SAME, LIGHT EMITTING ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT SUN2, PAH, FARS2 ERN1 3302/4885PIK3CD 4603/4885PIK3CA 4175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback